Navigation Links
EntreMed Reports First Quarter 2008 Financial Results
Date:5/2/2008

ROCKVILLE, Md., May 2 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial results for the three months ended March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The Company reported a net loss for the first quarter of approximately ($8.3 million), or ($0.10) per share, compared with a net loss of ($7.7 million), or ($0.09) per share, for the same period last year. The Company did not report any revenues for the first quarter 2008. As of March 31, 2008, the Company had cash and short-term investments of approximately $44 million.

Dane R. Saglio, EntreMed Chief Financial Officer, commented on the first quarter results, "The Company's first quarter 2008 financial results were in line with our projections. During the first quarter, the Company made the decision to invest behind Panzem(R) for rheumatoid arthritis rather than oncology, given 2ME2's mechanisms of action, safety profile and substantially larger market opportunity. Patients currently enrolled in Panzem(R) oncology trials will continue to receive treatment, and we expect to realize cost savings from the discontinuation of the program beginning in the second half of this year. We further expect operational expenses to remain at similar levels through the second quarter as we phase out the Panzem(R) NCD oncology program and advance the clinical development of ENMD-2076. Consistent with the past couple of years, we anticipate recording royalty revenue beginning in the third quarter and decreasing our research and development expenses slightly once the open Panzem(R) oncology trials conclude."

James S. Burns, EntreMed President and CEO commented, "Going forward, we will focus our resources on the development of our three onco
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
2. EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference
3. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
4. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
5. EntreMed Reports Third Quarter 2007 Financial Results
6. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
7. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
8. EntreMed to Present at the Bio 2007 Investor Forum
9. EntreMed Receives Deloitte Technology Fast 50 Award
10. Cepheid Reports Record Revenue of $44.8 Million
11. Cephalon Reports Strong First Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... May 25, 2013 A disorder of ... of peripheral neuropathy. According to neuropathy expert doctor Helen ... is estimated that the disorder affects almost 50% of ... arising from Diabetes. The high blood sugar levels in ... patients suffering from it usually tend to have abnormally ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... May 25, 2013 Pradaxa lawsuits ... life-threatening episodes of internal bleeding while using the blood thinner ... District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... Pradaxa side effect claims had been filed in ... from 705 claims reported by the Court on May 15th. ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 IBISWorld estimates ... grow at an average annual rate of 28.7% to $1.0 ... 17.9% in 2013. From 2002 and 2008, no new cell ... Culbert, causing relatively modest growth during that period. In the ... approved six new products. This factor contributed to the industry's ...
Breaking Medicine News(10 mins):Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3
... , Cancer Treatment Centers ... from Italy , PHILADELPHIA, Nov. 18 A radiation ... to the current average of six weeks, has arrived at ... CTCA will become the first in the country to offer this ...
... , , NEW YORK, Nov. ... kids, featuring reviews and commentary about products, discoveries on the ... kids behind WAT,s-THE-WORD?! are four young boys who helped their ... Cameron, age 10, recommended to his mom a "cooler" and ...
... , AUSTIN, Texas, Nov. 18 The Advisory Board of ... launch of a new online community for athletes overcoming accident, ... forum where athletes can share stories, set goals and report ... by providing encouragement, advice and mentoring. , IWillAgain.com is inspired ...
... , CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics ... announced today that it has entered into an underwriting agreement ... common share and 0.4 of a common share purchase warrant, ... proceeds of US$12,750,000. Each whole common share purchase warrant entitles ...
... , , WASHINGTON, Nov. 18 ... a wholly owned subsidiary of ULLICO Inc., a privately ... Prescription Solutions will provide pharmacy benefit management services to ... union trust funds, union employers and their members with ...
... 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in ... diseases. Nearly 30% of the users suffer from gastric ... the stomach, misoprostol, a non-selective prostaglandin E1 (PGE1) analogue, ... of NSAID-induced injuries, but often induces severe adverse effects. ...
Cached Medicine News:Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 2Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 3Health News:WAT-AAH!, The First Functional Bottled Water For Kids, Announces The Release of WAT's-THE-WORD?! 2Health News:IWillAgain.com Launches Online Community for Athletes Overcoming Accident, Illness or Injury 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 3Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 4Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 2Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 3
(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...
(Date:5/23/2013)... 2013  Ameritox, the nation,s leader in pain ... Inc. to become part of its Urine Drug ... costs and improve the clinical outcomes for injured ... benefit manager in the workers, compensation industry, has ... pain management strategy for several years. By establishing ...
(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...
Breaking Medicine Technology:TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... VILLAGE, Calif., Dec. 21 Specialists On Call, ... 10,000th emergency teleneurology consultation since the company,s inception. ... SOC,s leadership position as the largest private emergency teleneurology ... when it recently responded to a neurologic emergency at ...
... , LJUBLJANA, Slovenia, Dec. 21 Slovenian Minister of ... Novalis Tx(TM) radiosurgery platform for modern radiotherapy and radiosurgery ... platform from Varian Medical Systems (NYSE: VAR ... the country,s only radiotherapy department access to advanced radiotherapy ...
Cached Medicine Technology:Specialists On Call Delivers 10,000th Emergency Teleneurology Consultation 2Specialists On Call Delivers 10,000th Emergency Teleneurology Consultation 3Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 2Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 3Slovenia's Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB 4
... Leptin is a proteohormone with a molecular weight ... by the ob gene and produced by adipocytes [1,2]. ... in the regulation of body weight [1-3]. In ... in both men and women [4]. A relationship ...
ACTIVATED CLOTTING TIME SYSTEM...
... CT is a completely automated, ... performing clotting assays in random ... method of sample management offers ... of STAT samples without the ...
... ACTH (adrenocorticotropic hormone) is synthesized in the ... and is secreted into the peripheral circulation, ... 20 minutes [1]. ACTH is secreted in ... hypothalamus [1]. The actions of CRF are ...
Medicine Products: